What's Going To Happen With Tempus AI Stock Soon?

Resumen detallado
Tempus AI expects the deal to close in the fourth quarter of 2026, according to its latest quarterly filing. The company plans to pay for the deal in its Class A stock. It may…
Tempus AI (TEM) stock closed at $63.62 on November 18, 2026, down from its one-year high close of $85.08 on September 28. Management has also agreed to buy Personalis, a cancer-testing company that it says runs its tests at a loss. That deal goes to a Personalis shareholder vote on November 30, and Tempus AI reports results again in February. Below are the events most likely to move Tempus AI stock over the next six months.
Personalis shareholders vote on Tempus AI's purchase, with closing expected in the fourth quarter of 2026
Guardant Health reports fiscal Q4 2026 results, a read on demand for the kind of cancer tests Tempus AI also sells
Tempus AI reports fiscal Q4 2026 results, closing out its 2026 revenue guide
Personalis shareholders will vote on the transaction on November 30, 2026. Tempus AI expects the deal to close in the fourth quarter of 2026, according to its latest quarterly filing. The company plans to pay for the deal in its Class A stock. It may choose to pay up to 50% of the price in cash instead. Tempus AI already sells a Personalis test that monitors patients for cancer returning after treatment.
The catch is cost. Management said on the November 2 call that Personalis loses money on these tests, and that Tempus AI would absorb some of those losses once the deal closes. Tempus AI still reports a net loss. Management expects roughly $65 million of adjusted EBITDA, its own profit measure, for 2026, the same as in July. Even after taking on those losses, it expects that measure to keep improving in 2027.
Tempus AI expects only about $65 million of adjusted EBITDA for 2026, and Personalis will add its losses on top. If much of your savings sits in this one stock, a drop around the November 30 vote could hit you hard. When the market has fallen, the Trefis High Quality (HQ) Portfolio has lost about 81 cents for every $1 its benchmark lost, on average. See the HQ record.
Tempus AI expects to be paid more per cancer test starting in 2027.
Tempus AI's cancer…
Inicio del artículo, extracto de Yahoo Finance. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)



